Sunshine Novo (688621.SH): Clinical trial application for the BTP0427 research project approved

Zhitong Finance App News, Sunshine Nuohe (688621.SH) issued an announcement. Recently, the company and its wholly-owned subsidiary Jiangsu Nuohe Billituo New Pharmaceutical Research & Development Co., Ltd. received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration, and the clinical trial application for the company's research project BTP0427 was approved. BTP0427 is intended to be used to treat chronic heart failure with reduced ejection fraction. It is suitable for symptomatic treatment of patients with chronic heart failure with cardiac contractile dysfunction. As an alternative therapy, it is used for patients who have received the same dose of beta blockers in combination with sinus node IF current inhibitors and their condition is controlled.